Laetitia POUZOL, PhD, PharmD (she/her/hers)

Anaveon
Basel, Switzerland

I'm a translational scientist with a strong background in pharmaceutical drug discovery, preclinical development, and clinical support. At Anaveon, I focus on advancing novel immunotherapies, building on my experience leading small molecule program, particularly targeting GPCRs in autoimmunity and neuroinflammation, from early discovery through IND submission.

Prior to joining Anaveon, I held roles of increasing responsibility at Actelion, Idorsia, and Roche, where I specialized in pharmacology, immunology, and clinical biomarker strategy. I hold a Ph.D. in Immunology from the University of Paris-Saclay, as well as a Pharm.D. and an M.S. in Safety Pharmacology from the University of Lorraine.

Presentation(s):

• 0990: An Fc-engineered Agonistic anti-pd-1 Antibody Selectively Depletes pd-1⁺ Cells and Attenuates T Cell Activation in vitro and in vivo in a Xenogeneic Graft-versus-host Disease (GvHD) Model

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Anaveon AG: Employee (Ongoing); Idorsia Pharmaceuticals: Ownership Interest (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)